Ovarian serous adenocarcinomas express HAS2 and HAS3 [25], and Anttila et al. [26] reported that high levels of stromal HA predict poor prognosis in patients with epithelial ovarian cancer. This evidence concerns the gene HAS2 and ovarian carcinoma.